Skip to content

Broad Healthcare Sector

An Index Strategy For Concentrated Exposure To Biotech Disruptors

While biotech companies are some of the largest disruptors in the broader healthcare sector, broad healthcare indexes tend to lack concentrated biotech exposure. As such, for investors choosing to follow an index strategy, the author of today’s article highlights two indexes that offer exposure to biotech stocks that have one or more drugs in Phase II and Phase III U.S.…